Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06556602 · ClinicalTrials.gov registry record · NA

Methadone Patient Access to Collaborative Treatment

A NA study, sponsored by University of Arizona.

Not yet
Registry status
NA
Development phase
1,080
Enrollment target

NCT06556602: Clinical Trial NA study, sponsored by University of Arizona.

NCT06556602 is a NA study that has not yet begun recruiting, run by University of Arizona. The registered enrollment target is 1,080 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (23% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06556602, a NA study, has not yet begun recruiting, sponsored by University of Arizona.

NOT YET RECRUITING
Registry status
NA
Development phase
1,080 participants
Enrollment target

Study Summary

The trial of Methadone Patient Access to Collaborative Treatment (MPACT) will establish the impact of the intervention on patient outcomes of methadone treatment retention and in treatment overdose. It will also establish the impact of patient and staff trauma symptoms and clinic practice change on MPACT intervention implementation.

Primary Outcome

Time (days) to treatment interruption

Interventions

  • OTHER MPACT

Trial Details

FieldValue
Enrollment Target 1,080 participants
Start Date 2026-04
Est. Completion 2030-08
Phase NA
University of Arizona

349 total trials

What is known before NCT06556602 opens enrollment

NCT06556602 is an interventional study that assigns participants to a tested intervention. Its 1,080 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (23% lower).

The record links to 0 conditions, and to 1 intervention - of which MPACT is the first listed.

NCT06556602 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06556602 about?

NCT06556602 is a clinical study titled "Methadone Patient Access to Collaborative Treatment". The trial of Methadone Patient Access to Collaborative Treatment (MPACT) will establish the impact of the intervention on patient outcomes of methadone treatment retention and in treatment overdose. It will also establish the impact of patient and staff trauma symptoms and clinic practice change on...

What is the current status of trial NCT06556602?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,080 participants. The study started on 2026-04. Estimated completion is 2030-08.

What interventions are being tested in trial NCT06556602?

The interventions under investigation include: MPACT (OTHER).

Who is sponsoring clinical trial NCT06556602?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06556602's enrollment target sits among peer trials

1,080 95th of 2000 higher than 1,906 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06074068 · 1,080 participants · NA

    Father-Focused Intervention for Reducing Family Violence and Symptoms in Children

  • NCT07213804 · 1,080 participants · Phase 3

    A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer

  • NCT07084883 · 1,076 participants

    Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration

  • NCT06658808 · 1,075 participants · NA

    Efficacy-Implementation Study for PC CARES in Rural Alaska

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT06556602, the US trial registry maintained by the National Library of Medicine. NCT06556602 (large enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.